$Stericycle(SRCL.US$ soared more than 15% Friday on word that the medical-waste-disposal firm is considering a possible sale after receiving unspecified takeover interest.
SRCL rose 15.4% to a $51.65 close after Bloomberg quoted unnamed sources late in the session as saying that the company had received a takeover approach from an unspecified bidder or bidders.
The news agency didn't identify the interested party or parties, but quoted sources as s...
SRCL rose 15.4% to a $51.65 close after Bloomberg quoted unnamed sources late in the session as saying that the company had received a takeover approach from an unspecified bidder or bidders.
The news agency didn't identify the interested party or parties, but quoted sources as s...
1
Struggling genetic-testing firm $23andMe(ME.US$ rose more than 15% intraday Friday after reportedly beating analyst estimates on fiscal Q4 revenue.
ME rose as much as 16.7% to 59.48 cents per share, although the stock later retreated to 55.39 cents shortly before noon ET, ahead 8.7% on the day.
Shares gained ground after the firm reported Thursday after the bell that it lost 43 cents per share on $64 million in revenue in the three...
ME rose as much as 16.7% to 59.48 cents per share, although the stock later retreated to 55.39 cents shortly before noon ET, ahead 8.7% on the day.
Shares gained ground after the firm reported Thursday after the bell that it lost 43 cents per share on $64 million in revenue in the three...
4
$Petco Health and Wellness(WOOF.US$ rose more than 10% Thursday, extending a rally that's seen the retailer's stock gain nearly 30% since Tuesday's close following well-received quarterly results and forward guidance.
Petco added 10.1% to $3.17, adding to a 17.6% rally Wednesday that followed better-than-expected fiscal Q1 results from the pet-store chain. All told, the stock has risen 29.4% since Tuesday's $2.45 close.
...
Petco added 10.1% to $3.17, adding to a 17.6% rally Wednesday that followed better-than-expected fiscal Q1 results from the pet-store chain. All told, the stock has risen 29.4% since Tuesday's $2.45 close.
...
5
1
$AST SpaceMobile(ASTS.US$ fell more than 10% Tuesday after a three-session bull run drove the broadband company's stock up more than 140% in less than a week.
ASTS shed 10.8% to a $4.71 close, snapping a win streak that saw shares gain as much as 141.4% to a $5.77 intraday peak since closing last Wednesday at just $2.39.
AST SpaceMobile rallied last week on word that the company had signed a deal with $AT&T(T.US$ to make ...
ASTS shed 10.8% to a $4.71 close, snapping a win streak that saw shares gain as much as 141.4% to a $5.77 intraday peak since closing last Wednesday at just $2.39.
AST SpaceMobile rallied last week on word that the company had signed a deal with $AT&T(T.US$ to make ...
2
$Children's Place(PLCE.US$ sank some 20% Tuesday after the struggling retailer announced its CEO's departure.
PLCE fell as much as 23.3% to a $10.60 intraday low before partly recovering to end the session at $11.12, down 19.5% on the day.
Shares tumbled after the firm disclosed President and CEO Jane Elfers' exit. Board member Muhammad Umair will take over as president and interim CEO while the company looks for a n...
PLCE fell as much as 23.3% to a $10.60 intraday low before partly recovering to end the session at $11.12, down 19.5% on the day.
Shares tumbled after the firm disclosed President and CEO Jane Elfers' exit. Board member Muhammad Umair will take over as president and interim CEO while the company looks for a n...
2
Wall Street's meme-stock madness extended to more companies Tuesday, with $ProKidney(PROK.US$ and other names rising more than 25% despite no apparent news.
ProKidney -- a volatile biotech that's developing kidney-disease treatments – gained 33.8% to close at $4.12 even though the company had no news or other no obvious catalysts for the rally.
The stock has had a volatile history ever since going public in 2...
ProKidney -- a volatile biotech that's developing kidney-disease treatments – gained 33.8% to close at $4.12 even though the company had no news or other no obvious catalysts for the rally.
The stock has had a volatile history ever since going public in 2...
7
2
$SunPower(SPWR.US$, $iRobot(IRBT.US$ and other one-time meme stocks or SPAC darlings soared Monday as Wall Street partied like it's 2021.
The one-time super-hot names rallied in concert with 70%+ gains for former meme stocks $AMC Entertainment(AMC.US$ and $GameStop(GME.US$, which both rose more than 70%.
GME got the ball rolling by rallying Monday after an investor named "Roaring Kitty" -- who helped ...
The one-time super-hot names rallied in concert with 70%+ gains for former meme stocks $AMC Entertainment(AMC.US$ and $GameStop(GME.US$, which both rose more than 70%.
GME got the ball rolling by rallying Monday after an investor named "Roaring Kitty" -- who helped ...
6
$AMC Entertainment(AMC.US$ soared nearly 80% Monday to its highest close in more than four months as meme-stock mania seemingly returned to Wall Street.
AMC gained 78.4% to a $5.19 close -- apparently rising in sympathy with a massive rally in fellow meme-stock darling $GameStop(GME.US$, which gained 74.5%.
GME rallied on the first posting in some three years from "Roaring Kitty," a prominent backer of the stock on Reddit's Wa...
AMC gained 78.4% to a $5.19 close -- apparently rising in sympathy with a massive rally in fellow meme-stock darling $GameStop(GME.US$, which gained 74.5%.
GME rallied on the first posting in some three years from "Roaring Kitty," a prominent backer of the stock on Reddit's Wa...
9
3
$Ginkgo Bioworks(DNA.US$ fell some 10% after hours Thursday after the biotech missed analyst estimates for its Q1 revenue and announced plans to cut $200 million of operating expenses through layoffs and other steps.
DNA sank 10% to $0.83 a share shortly before 5 p.m. ET after the firm said Q1 revenues fell 53% from the same period last year to reach $37.9 million – below the $46.4 million consensus that analysts had reported expected.
Gink...
DNA sank 10% to $0.83 a share shortly before 5 p.m. ET after the firm said Q1 revenues fell 53% from the same period last year to reach $37.9 million – below the $46.4 million consensus that analysts had reported expected.
Gink...
3
2
$iHeartMedia(IHRT.US$ sank more than 35% Thursday to an all-time intraday low after the radio giant missed analyst expectation for its Q1 revenues.
IHRT fell as much as 37% intraday to a record $1.36 low after the firm reported $799 million in revenues – short of the $805.9 million consensus that analysts had been expecting.
IHeartMedia also recorded a $0.12 loss per share for the quarter, although that beat the $0.55 in red ink that analys...
IHRT fell as much as 37% intraday to a record $1.36 low after the firm reported $799 million in revenues – short of the $805.9 million consensus that analysts had been expecting.
IHeartMedia also recorded a $0.12 loss per share for the quarter, although that beat the $0.55 in red ink that analys...
2